Table 1.
Active compounds incorporated in multilayers.
Active Compound | Therapeutic Class | Incorporation Method | Polyelectrolytes Used | Reference |
---|---|---|---|---|
Diclofenac, Indomethacin | Analgesic | PE-AC interaction | PEI–PAA | [97] |
Ibuprofen | Analgesic | PE-AC interaction | CS–dextran sulphate CS–carboxymetylcelullose |
[127] |
Rifampicin | Antibiotic | Incorporation into hollow capsules | PVP–PMA | [128] |
Tetracycline | Antibiotic | PE-AC interaction | PAA–poly(L-lysine) | [129] |
Gentamicin | Antibiotic | PE-AC interaction | PSS–PAH | [130] |
Benzydamine | Anti-inflammatory agent | PE-AC interaction | CS–casein–poly(lactic acid) | [131] |
Artemisin | Chemotherapeutic agent | PE-AC interaction | CS–gelatin–ALG | [132] |
Paclitaxel Fluorouracil | Chemotherapeutic agent | PE-AC interaction | CS–dextran sulphate | [133] |
Mitoxantrone | Chemotherapeutic agent | Incorporation into hollow capsules and PE-AC interaction | PLL–PEG–block-poly(L-aspartic acid)–liposomal nanoparticles | [134] |
Doxorubicin | Chemotherapeutic agent | Incorporation into hollow capsules | CS–HA | [135] |
Insulin | Hormone | PE-AC interaction | Poly(malic acid)–CS | [136] |